Evolent Health, Inc. (EVH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 496.25M | 468.72M | 479.53M | 444.33M | 483.65M | 646.54M | 621.4M | 647.14M | 639.65M | 556.05M | 511.01M | 469.14M |
| Revenue Growth % | 2.6% | -27.5% | -22.83% | -31.34% | -24.39% | 16.27% | 21.6% | 37.94% | 49.56% | 45.4% | 44.93% | 46.63% |
| Cost of Goods Sold | 434.33M | 416.5M | 403.67M | 367.38M | 381.18M | 570.83M | 540.71M | 540.3M | 535.55M | 454.43M | 386.58M | 351.94M |
| COGS % of Revenue | 87.52% | 88.86% | 84.18% | 82.68% | 78.81% | 88.29% | 87.01% | 83.49% | 83.72% | 81.72% | 75.65% | 75.02% |
| Gross Profit | 61.92M | 52.22M | 75.86M | 76.94M | 102.47M | 75.71M | 80.69M | 106.84M | 104.11M | 101.63M | 124.43M | 117.2M |
| Gross Margin % | 12.48% | 11.14% | 15.82% | 17.32% | 21.19% | 11.71% | 12.99% | 16.51% | 16.28% | 18.28% | 24.35% | 24.98% |
| Gross Profit Growth % | -39.57% | -31.03% | -5.99% | -27.98% | -1.57% | -25.5% | -35.15% | -8.84% | -11.18% | 22.35% | 44.74% | 66.87% |
| Operating Expenses | 72.06M | 61.86M | 75.2M | 74.12M | 104.09M | 94.31M | 96.96M | 99.06M | 117.52M | 122.98M | 142.37M | 138.77M |
| OpEx % of Revenue | 14.52% | 13.2% | 15.68% | 16.68% | 21.52% | 14.59% | 15.6% | 15.31% | 18.37% | 22.12% | 27.86% | 29.58% |
| Selling, General & Admin | 72.06M | 61.86M | 75.2M | 74.12M | 78.41M | 47M | 67.06M | 69.19M | 79.1M | 81.43M | 96.57M | 90.39M |
| SG&A % of Revenue | 14.52% | 13.2% | 15.68% | 16.68% | 16.21% | 7.27% | 10.79% | 10.69% | 12.37% | 14.64% | 18.9% | 19.27% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.6M | 6.6M | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | 1.19% | 1.29% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -10.14M | -9.64M | 658K | 2.83M | -1.62M | -18.6M | -16.27M | 7.79M | -13.41M | -21.35M | -17.94M | -21.57M |
| Operating Margin % | -2.04% | -2.06% | 0.14% | 0.64% | -0.34% | -2.88% | -2.62% | 1.2% | -2.1% | -3.84% | -3.51% | -4.6% |
| Operating Income Growth % | -524.97% | 48.16% | 104.04% | -63.71% | 87.9% | 12.9% | 9.31% | 136.11% | -29.49% | -1036.85% | -238.51% | -365.53% |
| EBITDA | 12.35M | 35.4M | 27.45M | 27.25M | 22.44M | 11.89M | 13.43M | 37.66M | 16.09M | 8.25M | 16.8M | 10.57M |
| EBITDA Margin % | 2.49% | 7.55% | 5.73% | 6.13% | 4.64% | 1.84% | 2.16% | 5.82% | 2.52% | 1.48% | 3.29% | 2.25% |
| EBITDA Growth % | -44.96% | 197.6% | 104.38% | -27.63% | 39.41% | 44.13% | -20.04% | 256.41% | -14.94% | -53.91% | -44.28% | 0.83% |
| D&A (Non-Cash Add-back) | 22.49M | 45.04M | 26.8M | 24.43M | 24.06M | 30.49M | 29.7M | 29.87M | 29.5M | 29.6M | 34.74M | 32.13M |
| EBIT | -10.14M | -9.64M | 658K | 2.83M | -52.76M | -17.2M | -17.75M | 6.47M | -10.72M | -35.83M | -16.26M | -20.84M |
| Net Interest Income | -15.85M | -18.14M | -15.51M | -10.52M | -9.11M | -5.89M | -5.22M | -4.63M | -3.45M | -9.72M | -13.54M | -13.85M |
| Interest Income | 1.01M | 868K | 964K | 1.08M | 1.27M | 830K | 794K | 1.37M | 2.55M | 2.52M | 1.07M | 604K |
| Interest Expense | 16.87M | 19.01M | 16.48M | 11.6M | 10.38M | 6.72M | 6.01M | 6M | 6M | 12.24M | 14.61M | 14.46M |
| Other Income/Expense | -15.59M | -421.17M | -20.62M | -23.55M | -61.53M | -5.33M | -7.49M | -6.43M | -3.31M | -26.72M | -12.94M | -13.72M |
| Pretax Income | -25.72M | -430.81M | -19.96M | -20.72M | -63.15M | -23.92M | -23.76M | 1.36M | -16.71M | -48.07M | -30.87M | -35.29M |
| Pretax Margin % | -5.18% | -91.91% | -4.16% | -4.66% | -13.06% | -3.7% | -3.82% | 0.21% | -2.61% | -8.64% | -6.04% | -7.52% |
| Income Tax | 910K | -1.68M | 906K | -825K | 1.47M | -1.12M | -619K | -238K | 565K | -14.66M | -5.55M | -970K |
| Effective Tax Rate % | -3.54% | 0.39% | -4.54% | 3.98% | -2.33% | 4.69% | 2.61% | -17.53% | -3.38% | 30.49% | 17.98% | 2.75% |
| Net Income | -26.63M | -429.13M | -20.86M | -19.9M | -64.62M | -22.8M | -23.14M | 1.6M | -17.28M | -33.41M | -25.32M | -34.32M |
| Net Margin % | -5.37% | -91.55% | -4.35% | -4.48% | -13.36% | -3.53% | -3.72% | 0.25% | -2.7% | -6.01% | -4.96% | -7.32% |
| Net Income Growth % | 58.79% | -1781.99% | 9.82% | -1346.68% | -273.95% | 31.75% | 8.64% | 104.65% | 13.52% | -194.4% | -1292.84% | -648.1% |
| Net Income (Continuing) | -26.63M | -429.13M | -20.86M | -19.9M | -64.62M | -22.8M | -23.14M | 1.6M | -17.28M | -33.41M | -25.32M | -34.32M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -3.76 | -0.24 | -0.44 | -0.63 | -0.27 | -0.27 | -0.06 | -0.22 | -0.36 | -0.30 | -0.31 |
| EPS Growth % | 61.9% | -1292.59% | 11.11% | -689.95% | -186.36% | 25% | 10% | 82.03% | -15.79% | -227.27% | -1600% | -576.86% |
| EPS (Basic) | -0.24 | -3.76 | -0.24 | -0.44 | -0.63 | -0.27 | -0.27 | -0.06 | -0.22 | -0.36 | -0.30 | -0.31 |
| Diluted Shares Outstanding | 111.91M | 114.21M | 114.07M | 115.88M | 115.31M | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M | 112.28M | 111.28M |
| Basic Shares Outstanding | 111.91M | 114.21M | 114.07M | 115.88M | 115.31M | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M | 112.28M | 111.28M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |